Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Nov 24, 2020

Keywords

ClinConnect Summary

This clinical trial is designed to compare different types of medications that help prevent kidney stones. Specifically, it will look at over-the-counter options and alternative prescription medications against a medication called slow-release potassium citrate. The goal is to see which of these treatments is most effective at changing the substances in urine that can lead to stone formation.

To participate in this study, you need to be an adult aged 18 or older, and you can either have a history of kidney stones or not. However, if you are pregnant, nursing, or unable to follow a specific diet related to this study, you won’t be eligible to join. The trial is not yet recruiting participants, but once it starts, those who qualify will take the medications and provide information about their experiences, helping researchers understand how well each treatment works in reducing the risk of kidney stones.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 and older.
• • with or without a history of stone disease.
• Exclusion Criteria:
• • They are unable to take any of the medications due to health reasons.
• • Participants are pregnant or nursing.
• • Participants are unable to adhere to the metabolic diet.
• • Participants had a prior adverse event from one or more of the medications.